Drug Diversion Monitoring Software Product Ranking Comparison

<a href="https://klasresearch.com/compare/drug-diversion-monitoring/365" target="_blank"><u style="color:#4c8bc9;">Drug diversion monitoring</u></a> is a key area that helps healthcare organizations improve patient safety and prevent drug waste and misuse. The second generation of drug diversion monitoring solutions utilizes predictive models, artificial intelligence (AI), and machine learning (ML), and users are beginning to see outcomes such as correctly identified risks, reduced false positives, and increased efficiency. This report examines which vendors are driving outcomes, how advanced AI/ML capabilities are impacting the user experience, and how well vendors partner with and support customers.

Recent Insights

Key Findings:

Bluesight & Protenus Customers Want Continued Development for Advanced Capabilities; Invistics’ Smaller Customer Base Seeing Success with AI
Invistics & HelioMetrics Performing Well Despite Limited Market Adoption; Imprivata Customers Report Continued Struggles Post-Acquisition
Despite Advancing Integration, BD Customers Continue to Experience Functionality Challenges
Protenus Leads in Supporting Customers and Keeping Promises; Bluesight Customers Feel Support Is Declining as Vendor Grows

Performance Data

Overall Score by Product

Products Appearing in Decisions

Overall Score by Question Topic

Provider Facility Size by Product

Provider Facility Type by Product

Though the COVID-19 pandemic has been a major focus for the past few years, drug diversion is still a pressing problem for healthcare organizations. This can potentially involve lawsuits, federal fine

We are all aware of the fact that healthcare lags behind other industries. Barriers such as heavy regulations and intense scrutiny weigh down technological advancements. And as KLAS’ Medication Invent

Decision Insights

Drug Diversion Monitoring 2021

04 January 22 | Jackson Tate and Jennifer Hickenlooper

In the last 12 months, KLAS has interviewed 41 healthcare organizations that have recently purchased a drug diversion monitoring solution or are in the process of doing so. This represents a sharp increase in market activity. Several factors are fueling the growth, including greater awareness of the opioid crisis as well as a greater need during the COVID-19 pandemic for visibility and automation when it comes to managing medication inventories. Additionally, organizations are considering several newer technology options purported to offer more intuitive workflows and more complete investigational tools. This report examines recent and upcoming drug diversion monitoring purchase decisions to determine which vendors are generating the highest interest.

Drug Diversion Monitoring

Latest Category Report